• Español
  • English
Registration Form
 
Abstract Submission Form
 
Remaining Time
 
Days

  • Hou.
  • Min.
  • Sec.
Topics
  • Precongress John Humphrey Advance Immunology Course.
    Glauber Rocha, Havana, March 19-22, 2012
Allergen Vaccines
  • Immunology and Molecular Allergology symposium:
    • Progress in novel allergen vaccines, recombinant allergens.
    • Modified versus non modified allergen vaccines.
    • Allergen structure and function.
    • Adjuvants for allergen vaccines.
    • Mucosal routes and immunity.
    • Interaction of allergens with innate immunity.
    • Allergy and parasitism: relevance to allergen and parasitic vaccines.
  • Pharmaceutical development symposium:
    • Analytical development, potency and major allergen assays, reference system.
    • Challenges in stability studies, ICH compliance.
    • Formulation development, injections and sublingual route.
    • Quality issues and process development, validation, natural and recombinant products.
  • Allergen standardization and Regulatory problems symposium:
    • Centralized Registration of Allergen Products in Europe.
    • Regulatory Approach to Allergen Products in USA.
    • Developing the Regulatory Status of allergen products in Latin America.
  • Clinical Trials symposium:
    • Design of clinical trials: efficacy endpoints, immunological markers, provocation tests, confirmatory studies.
    • Preliminary, phase I, and dose-finding studies.
    • Long-term efficacy markers, immunological memory mechanisms.
    • Safety, pharmacovigilance studies
    • Clinical Trials in children
  • Special WAO-AAAAI Symposium on Subcutaneous Immunotherapy (R. Lockey, D. Ledford, USA):
    • Practice parameters.
    • Cost-effectiveness of SCIT.
    • Efficacy and immunologic changes included by SCIT.
  • Allergome Platform Course for Molecular Allergologists (Prof. Adriano Mari, Italy).
Adjuvants
  • New generation of adjuvants:
    • Immunobiology of adjuvants, immune activation.
    • Immunological mechanisms: long-lived memory T-cell induction, Th-1/Th-2 cell polarization.
    • Microbe-derived immunostimulants (TLR agonist, CpG, etc).
    • Particulate immunostimulants (VLPs, oil-in-water, PLGA,etc).
    • Synthetic molecules.
  • Adjuvants to Influenza Vaccines and other Respiratory Diseases:
    • pandemic and seasonal.
    • friendly platform of immunization.
    • intradermal, skin delivery, microneedle immunization.
  • Adjuvants to Sexually Transmitted Infections:
    • Genital herpes, chlamyda, chancroid, HIV, etc.
    • Mucosal responses and immunity.
  • Adjuvants to Allergy Vaccines:
    • Sublingual, subcutaneous, intradermal immunization.
    • Skin delivery.
    • TLR, mucosal routes and immunity.
  • Adjuvants to Tuberculosis Vaccines:
    • Mucosal adjuvants.
    • Micobacterial TLR ligands.
    • Micro or nanoparticles, Cationic lipids.
    • Adjuvants combinations and delivery.
  • Adjuvants to anti-Parasite Vaccines:
    • Leishmania, malaria and Schistosoma and other.
  • Adjuvants to Cancer Vaccines:
    • Cytokines, dendritic cells.
    • Strategies to polarize the immune response.
    • Effector and memory T cells.
    • Therapeutic efficacy against tumors.
  • Adjuvants in Veterinary Vaccinology:
    • Animal species.
    • Route of immunization.
    • Type of immunity needed.
  • Immunotoxicology.
Organized by:
SCI ALAI
Endorsed by:
WAO CNSCS
Sponsors:
The Organizing Committee is welcoming the support from interested organizations. Please contact us for questions. We express our gratitude to the following sponsors:
BioCen Finlay CIM Inmunotek INBio Infomed Ediciones Finlay SCAAIC Quimefa Allergome SEPPIC CITEQ FDA/ALLERGENIC MERCK